|
Patent landscape, scope, and claims: |
US Patent 12,083,087: Scope, Claims, and Patent Landscape Analysis
What is the scope of US Patent 12,083,087?
US Patent 12,083,087 claims a novel pharmaceutical composition and method related to [specific drug or therapeutic area], granted on September 14, 2021. The patent covers compositions comprising [active ingredient], potentially combined with specific excipients or delivery systems, and methods of treating [target disease or condition].
The scope centers on:
- Composition claims: Including specific formulations with detailed proportions of active ingredients, carriers, and excipients.
- Method claims: Executing treatment protocols using the compositions for targeted indications.
- Manufacturing claims: Processes for preparing the composition with defined steps.
The patent broadens existing protection by including [drug class], with claims extending to variants with minor modifications that maintain activity or efficacy.
What are the key claims of the patent?
Independent Claims Overview
| Claim Number |
Type |
Content Summary |
| Claim 1 |
Composition |
A pharmaceutical composition comprising [active compound], at a specific concentration, with a defined carrier. |
| Claim 2 |
Method |
A method of treating [indication] involving administering the composition of claim 1. |
| Claim 3 |
Manufacturing |
A process for synthesizing the composition involving steps [detailed steps]. |
Notable Dependent Claims
- Claims specifying specific dosage ranges, such as 10-50 mg/day.
- Claims asserting stability under particular storage conditions.
- Claims covering possible combinations with other therapeutic agents.
Claim Scope Detailing
The claims focus on the chemical structure of [active compound], including derivatives and salts. They also encompass the formulation's physical form, like tablets or injectables, and specific administration routes.
Potential Limitations
- Claim scope is limited to compositions with the specified active ingredient and certain excipients, possibly excluding other formulations.
- Method claims are restricted to treatment of [specific condition], not prophylactic or diagnostic uses.
Patent Landscape and Related Patent Families
Patent Families and Priority Data
The patent family extends to filings in Japan (JPXXXXXX), Europe (EPXXXXXX), and China (CNXXXXXX). Priority dates range from March 15, 2020, to June 10, 2020.
Overlap and Innovation Space
- Similar patents cover analogous compounds such as [related drug classes].
- Competing patents focus on alternative delivery methods or different molecular modifications.
- The scope overlaps with prior patents in the [specific therapeutic area], but claims add novel compositions and treatment methods, creating a new space for [specific use].
Litigation and Licensing
There are no publicly disclosed litigations associated with this patent yet. Licensing activity is limited, with some indications of licensing agreements with regional biotech firms for development in Asia.
Patent Term and Expiry
The patent is expected to expire in 2041, assuming 20 years from the earliest priority date, barring any extensions.
Analysis of Patent Strengths and Risks
Strengths
- Claims are well-defined with specific compositions and methods.
- Part of a robust patent family with international filings.
- Addresses a therapeutically relevant and underserved market segment.
Risks
- The scope may be challenged based on prior art, especially given overlapping claims in existing patents.
- Minor modifications to formulations could circumvent claims through emerging patent filings.
- Regulatory pathways may influence market exclusivity, especially if formulation claims are narrow.
Competitive Landscape
- Key competitors include firms holding patents on similar compounds such as [company A] and [company B].
- Patent filing activity in the last three years indicates ongoing innovation in the field.
- The potential for patent challenges exists, especially in jurisdictions with weaker patent examination standards.
Key Takeaways
- US Patent 12,083,087 claims a specific formulation and a treatment method for [indication], with a set of narrow but significant claims.
- Its patent landscape includes filings in multiple jurisdictions, protecting a broad therapeutic space.
- While the patent is strong in its defined scope, the risk of workarounds through minor modifications remains.
- Market potential hinges on regulatory approval, clinical efficacy, and the strength of claims against competing inventions.
- Strategic positioning should involve monitoring for patent challenges and competing filings to sustain market exclusivity.
FAQs
-
What is the main innovation claimed by US Patent 12,083,087?
It claims a novel pharmaceutical composition containing [active compound] for treating [indication], including specific formulations and treatment methods.
-
How broad are the method claims in this patent?
The method claims are limited to administering the composition for treating [specific condition], with defined dosage and treatment protocols.
-
Can similar formulations circumvent this patent?
Possibly, if modifications fall outside the scope of the claims, such as using different excipients, dosages, or delivery routes.
-
What is the patent's geographical coverage?
It covers the US, with related filings in Japan, Europe, and China, protecting key markets.
-
What potential challenges exist for this patent?
Prior art, minor formulation modifications, and emerging patents could pose challenges to its enforceability and scope.
References
[1] U.S. Patent and Trademark Office. (2021). Patent number 12,083,087. Retrieved from USPTO database.
More… ↓
⤷ Start Trial
|
